SMA Newsroom

Meetings & conferencesSMA EventsJun 14, 2022

SMA Europe Annual Meeting, Rome

Last week SMA Europe held its' Annual Meeting and General Assembly. This year, we were hosted by Famiglie SMA in beautiful and sunny Rome.


ResearchTreatmentsClinical trialsMay 31, 2022

Roche Community Update: FDA (U.S. Food and Drug Administration) approves a label expansion for risdiplam

Today, the U.S. Food and Drug Administration (FDA) has approved a label extension for Evrysdi® (risdiplam) to include babies under two months old with spinal muscular atrophy (SMA). This means that risdiplam is now approved in the US to treat SMA in children and adults of all ages. 

OtherAdvocacyRare DiseasesUkraine May 27, 2022

News from Ukraine: Interview with Maria

Listen to interview with Maria. She speaks to us from Ukraine about her reality, her story and her plans for when the war is over.